对RA的新免疫和炎症相关诊断生物标志物的验证
1Department of Rheumatology, Hexian People's Hospital, Ma'anshan City, Anhui Province, China. Baoxijie2023@126.com.
Clinical rheumatology
|January 29, 2024
概括
这项研究确定了五个关键基因 (TNFSF10,IL1R1,CXCL9,ACVR1B和IL15) 作为类风湿性关节炎 (RA) 的潜在诊断生物标志物. 这些与免疫和炎症相关的基因显示出早期RA诊断和治疗策略的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是免疫细胞参与和炎症.
- 确定RA可靠的生物标志物对于有效的预防,诊断和治疗策略至关重要.
研究的目的:
- 确定与类风湿性关节炎相关的新型免疫和炎症相关基因 (DE-IIRGs).
- 使用生物信息学方法选潜在的RA诊断生物标志物.
主要方法:
- 使用limma包的差异基因表达分析.
- 不同表达基因 (DEGs) 与免疫和炎症基因集的交叉.
- 拉索回归用于生物标志物识别和蛋白质与蛋白质相互作用 (PPI) 网络的构建.
- 免疫透分析和药物预测.
主要成果:
- 确定了20个差异表达的免疫和炎症相关基因 (DE-IIRGs).
- 选择了五个基因 (TNFSF10,IL1R1,CXCL9,ACVR1B和IL15) 作为潜在的RA诊断生物标志物.
- 与对照组相比,在RA患者中观察到CXCL9,IL15和TNFSF10的表达升高.
- 在RA样本中,免疫细胞透率显著增加.
结论:
- 提议TNFSF10,IL1R1,CXCL9,ACVR1B和IL15作为类风湿性关节炎的新型诊断生物标志物.
- 这些发现为早期诊断RA提供了潜在的理论基础.
- 鉴定的生物标志物可能有助于改善RA的管理和治疗策略.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334


